Faculty & Research

Faculty & research are integral components of BME. With a strong focus on research, BME is located in the heart of Canada’s largest health-care research hub. Our graduate students receive their training from 14 departments at U of T, 10 partner hospitals, and 7 research institutes & commercialization centres.

At BME, our cross-disciplinary approach in biomedical and clinical engineering enables our researchers to cover a diverse set of topics. Find out what our research publication are saying about our research focus.

Faculty directory

Core Faculty

We have 30+ core faculty members that span across cell & tissue engineering, clinical engineering, and molecular engineering disciplines.

Cross-Appointed Faculty

BME currently hosts cross-appointed faculty members across more than 30 academic units, partner hospitals, research institutes, and commercialization centres.

Emeriti

Learn about some of our retired faculty members

Research streams

Clinical

BME’s clinical engineers design technologies, devices and strategies for people with chronic disease, traumatic injury, disabilities and mobility limitations to help them integrate more fully with their environment.

Cell & Tissue

Research that has the potential to change how we think about disease and aging is happening at BME. Regenerative medicine uses stem cells and biomaterials to repair, replace or regenerate damaged tissue, organ structures and function.

Molecular

BME researchers are advancing disease detection, customizing drug delivery and improving health-care outcomes with faster and more precise technologies and systems.

Latest news

Professor Elaine Biddiss Receives CIHR Grant to Advance Digital Motor Rehabilitation for Children with Disabilities

Professor Elaine Biddiss receives CIHR grant to advance digital motor rehabilitation for children with disabilities Young people with motor disabilities […]

Professor Jonathan Rocheleau Awarded CIHR Grant to Investigate Key Mechanism in Diabetes Treatment

Professor Jonathan Rocheleau, a researcher at the University Health Network (UHN) and the Institute of Biomedical Engineering (BME), has received a $100,000 grant from the Canadian Institutes of Health Research (CIHR) to explore a crucial aspect of insulin release—a process essential for maintaining healthy blood sugar levels.

Restoration of Rapid Wound Repair Despite Immunosuppressants

Researchers at U of T have determined that immunosuppressants used with transplant recipients slow wound repair by inhibiting the growth of cells adjacent to wounds. They have found ways to restore rapid wound repair in an in vivo animal model.

New drug delivery system could improve glaucoma treatment

Researchers from the Institute of Biomedical Engineering and Chemical Engineering at the University of Toronto have developed a novel method to dramatically extend the duration of glaucoma treatment.

U of T to host new national hub for accelerating life sciences breakthroughs

The University of Toronto and its partners are receiving $4.25 million over the next five years to establish a national hub aimed at accelerating the commercialization of life sciences discoveries.

New study points to leg muscle as a potential early warning system for heart failure

Researchers at the University of Toronto’s Institute of Biomedical Engineering (BME) have found that studying blood flow in leg muscles may help detect cardiovascular disease earlier compared to standardized tests, opening the door to earlier treatment and better outcomes.

Faculty startups

The following list highlights some of the startup companies that have been launched by these forward-thinking faculty members, demonstrating their commitment to translating academic knowledge into real-world applications and making a significant impact on the biomedical industry.

Faculty Member Commercialization Venture Focus Location 
Jan Andrysek LegWorks Prosthetic Knee Joint San Francisco 
John E. Davies Tissue Regenerative Therapeutics Inc. Mesenchymal Stem Cells Toronto 
Milos PopovicMyndTech Inc. Medical Tech Company Mississauga 
Milica Radisic Tara Biosystems Cardiac Drug Discovery New York 
Jonathan Rocheleau QuantM3 Microfluidics Technology Diabetes Treatment Toronto 
Paul SanterreInterface Biologics Drug Delivery and other technologies Toronto 
Paul Santerre and Eli Sone Cohesys Inc Bone Tape to replace plate and screws in craniofacial repair; Angel investment Toronto 
Paul Santerre Ripple Therapeutics Non-polymeric anti-inflammatory drug delivery systems for ophthalmology; venture invested Toronto 
Molly Shoichet AmacaThera Injectable hydrogel platform technology Toronto 
Aaron Wheeler Miroculus (formerly Kappex) Digital Microfluidics Platform Toronto